Womens Health Diagnostics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, France, UK, China - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 181 SKU: IRTNTR75955

Women's Health Diagnostics Market Forecast 2023-2027

The global women's health diagnostics market size is estimated to grow by USD 13.35 billion at a CAGR of 7.93% between 2022 and 2027. The increasing prevalence of breast cancer, driven by various factors including lifestyle changes and aging populations, is driving market growth by increasing the demand for breast cancer screening, diagnosis, and treatment options. The increasing infertility rate in women, attributed to factors such as delayed childbearing and lifestyle factors, is also boosting market expansion by creating a demand for fertility treatments and services. Additionally, the increasing prevalence of sexually transmitted diseases (STDs), driven by changes in sexual behavior and inadequate access to healthcare, is driving the demand for STD testing, treatment, and prevention products. 

STDs are caused by the transmission of different bacteria, viruses, and parasites due to the exchange of vaginal fluids. There are more than 30 different bacteria, viruses, and parasites that can cause STDs. All through life, STDs have had a disproportionately negative impact on women. Syphilis, gonorrhea, chlamydia, hepatitis B, genital herpes, and HIV are among the several STDs. Major contributors to pelvic inflammatory illness and infertility in women are gonorrhea and chlamydia. The increasing incidences and prevalence of STDs are increasing the demand for screening and diagnosis of STDs at the earliest to reduce the chances of mortality. companies present across the globe are focusing on offering a wide range of STD-testing drugs.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

 

Market Segmentation 

This report provides a detailed analysis of the market by Application (Breast cancer testing, Infectious disease testing, STD testing, Cervical cancer testing, and Others ), End-user (Hospitals and clinics, Diagnostic and imaging centers, and Home care settings ), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

By Application 

The market share growth by the breast cancer testing segment will be significant during the forecast period. A biopsy is the only reliable method for identifying breast cancer. The doctor performs a biopsy by using a specialized needle instrument to remove a core of tissue from the location while being guided by an X-ray or other imaging test.

Get a glance at the market contribution of various segments View a PDF Sample

The breast cancer testing segment was valued at USD 6.27 billion in 2017. Biopsy samples are analyzed in a laboratory to determine whether or not they contain cancer cells. The type of cells involved in breast cancer, its aggressiveness (grade), and whether the cancer cells have hormone receptors or other receptors that could affect treatment options are all determined by analyzing a biopsy sample.

By End-user 

Hospitals and clinics

Over the years, hospitals and clinics have developed advanced medical infrastructure to cater to the needs of people. One of the major focus areas in hospitals is to increase the screening, monitoring, and diagnosis of various chronic diseases, such as cervical cancer and breast cancer in outpatient settings. For women who do not have other sources of screening, the opportunity to perform diagnostic tests in a hospital or clinical setting is available. An accurate test for cancer, such as a biopsy test, during hospital admission, plays a vital role in reducing the mortality rates of breast and cervical cancer. With an increase in the number of hospitals and clinics and the increased convenience provided by them, they are expanding women's health diagnostic services related to infertility, gynecology, menopause, and others, which have provided patients with a broader range of treatment options to choose from based on cost and effectiveness. Also, with an increase in the number of hospitals and clinics, there is easier access to women's health diagnostic services.

Diagnostic and imaging centers

Due to the increasing prevalence of chronic and infectious diseases and associated risk factors among women, the rapidly growing elderly women population, and the increasing number of women health studies and surgical imaging procedures, the diagnostic and imaging center segment is expected to grow steadily during the forecast period. Diagnostic imaging, which supports the diagnosis and treatment of diseases, has rapidly evolved into a vital role in modern medicine. In addition, diagnostics and imaging equipment have been constantly developed by companies operating on the market. With the rising number of chronic diseases among women and investment in the healthcare sector, diagnostic and imaging centers will witness growth, which, in turn, is expected to propel the growth of the global market during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America has been witnessing an increase in the adoption of various advanced diagnostic technologies over the past few years. In this region, the majority of market growth is due to technological adoption, increasing health care expenditure, rising prevalence of diseases like cancer, and increased levels of awareness about breast cancer screening and diagnosis. This is one of the most common chronic diseases found in people in this region. According to the CDC, breast cancer is one of the most common types of cancer in women, and it is the second leading cause of cancer deaths among women in the US.

Buy Now Full Report and Discover More

Key Women Health Diagnostics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories, Becton Dickinson and Co. - The company offers women's health diagnostics such as menstrual medicine called Duphaston and Iberet Folic 500.

  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • Exact Sciences Corp.
  • F. Hoffmann La Roche Ltd.
  • FUJIFILM Corp.
  • GE Healthcare Technologies Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Invitae Corp.
  • Myriad Genetics Inc.
  • Natera Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Quidelortho Corp.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • and Koninklijke Philips N.V.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

 

The market is crucial for addressing a range of conditions, including infectious diseases like hepatitis and urinary tract infections. Advanced diagnostic technologies such as digital and mobile mammography, breast MRI, and ultrasound play a vital role in the early detection of breast cancer. Additionally, diagnostics for osteoporosis through bone density testing are important for women's health. The market also focuses on sexual and reproductive health, including diagnostics for STDs and infertility. With a growing emphasis on preventive care, diagnostics for cancer and other conditions are gaining prominence. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The increasing prevalence of breast cancer is driving growth in the women's health diagnostics market. Cancer is a widespread chronic disease that is increasingly becoming a significant health concern, contributing to the rising global mortality rates. Among the various types of cancer, breast cancer stands out as one of the most common forms affecting women. The growing prevalence of breast cancer is closely linked to the expanding elderly population, as it is more commonly diagnosed in older women worldwide. This trend underscores the importance of regular screening and early detection methods such as digital and mobile mammography, breast MRI, ultrasound, and bone density testing, especially for women-centric conditions. To combat the impact of breast cancer, regular screening is essential for women globally to detect any signs or symptoms early and reduce mortality rates. The demand for screening has surged worldwide due to the escalating death rates associated with the disease. Healthcare professionals recommend and conduct diagnostic procedures such as X-rays or MRIs to detect breast cancer in patients, which is expected to drive market growth in the forecast period.

Significant Market Trends

The adoption of advanced diagnostic solutions is a primary trend in the market. Breast cancer management and infectious disease testing using immunoassay and molecular diagnostic technologies are becoming more and more common. The availability of advanced treatment care also enables increased adoption rates among healthcare providers. The growth of specialist tests in esoteric, pathology, and genetic areas will continue to grow over the forecast period even though currently there is more activity associated with normal diagnostics. The increased need for diagnostic products encourages companies to focus on providing customized automation solutions to address the needs of patients. 

Moreover, the adoption of point-of-care testing (POCT) is rising globally due to its efficient workflow process and advantages such as the ability to be performed at the bedside, portability, and timely and rapid diagnosis. Thus, the increasing adoption of advanced diagnostics solutions will propel the growth of the market focus during the forecast period.

Major Market Challenges

The lack of trained laboratory technicians is a major challenge in the market challenge.  Trained professionals with better dexterity skills, able to handle tools and perfectly perform procedures, are required for almost all of the critical diagnostics tests like immunoassays and molecular diagnosis. The need for expensive and multi-year theoretical studies to become qualified professionals or technicians also contributes to the shortage of trained laboratory technicians. An important role in the early detection and treatment of diseases is to be played by expertise and skills in handling and use of diagnostic tools.

Moreover, the market has a shortage of trained professionals who can handle technologically advanced diagnostic devices. The results of tests may be affected due to errors in data input, which can have an impact on diagnosis using automatic handling systems. The lack of expertise is likely to lead to an incorrect diagnosis. Trained professionals must handle automated handling systems, as accuracy and reliability play a vital role in laboratories. Hence, the limited number of trained staff will negatively affect market growth during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook 
    • Breast cancer testing
    • Infectious disease testing
    • STD testing
    • Cervical cancer testing
    • Others
  • End-user Outlook 
    • Hospitals and clinics
    • Diagnostic and imaging centers
    • Home care settings
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Australia
      • Brazil

Market Analyst Overview

The market is experiencing significant advancements, especially in breast cancer diagnosis and treatment facilities, aided by technologies like Digital Breast Tomosynthesis (DBT) and Imagio Breast Imaging System. There's a growing focus on fertility assessments and addressing menstrual abnormalities to improve reproductive health. The market also addresses prevalent issues like osteoporosis and chronic liver disease, often linked to calcium or vitamin D shortages and hepatitis B virus (HBV). With rising concerns over SARS-CoV-2 and other infectious diseases, the market is witnessing the development of rapid diagnostic tests and portable point-of-care devices. Collaborations and partnerships, such as Hologic's Project Health Equality, aim to reduce disparities in healthcare quality and enhance cancer detection rates, including for ovarian cancer and colon cancer.

The market encompasses a wide array of areas in medical science, including AIDS management, osteoporosis prevalence, and Mycobacterium TB illness detection. It also focuses on the prenatal segment for monitoring maternal health and fetal development. Diagnostic centers play a crucial role, offering services for various conditions such as ovarian, uterine, and vaginal infections. Technologies like portable and point-of-care devices enhance accessibility to healthcare. The market addresses chronic and lifestyle-related disorders like obesity, drug abuse, and alcohol use through advanced diagnostics. Collaborations with institutions like the Census Bureau and NIH drive research on fertility rates and reproductive age for better breast cancer management, including testing for benign breast lesions.

 Market Scope

Report Coverage

Details

Page number

181

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.93%

Market growth 2023-2027

USD 13.35 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

6.95

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Canada, France, UK, and China

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann La Roche Ltd., FUJIFILM Corp., GE Healthcare Technologies Inc., Hologic Inc., Illumina Inc., Invitae Corp., Myriad Genetics Inc., Natera Inc., PerkinElmer Inc., QIAGEN NV, Quest Diagnostics Inc., Quidelortho Corp., Siemens AG, Thermo Fisher Scientific Inc., and Koninklijke Philips N.V.

Market dynamics

Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global womens health diagnostics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global womens health diagnostics market 2017 - 2021 ($ million)
    • 4.2 Geography Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 End-user Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Breast cancer testing - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Breast cancer testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Breast cancer testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Breast cancer testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Breast cancer testing - Year-over-year growth 2022-2027 (%)
    • 6.4 Infectious disease testing - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Infectious disease testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Infectious disease testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Infectious disease testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Infectious disease testing - Year-over-year growth 2022-2027 (%)
    • 6.5 STD testing - Market size and forecast 2022-2027
      • Exhibit 42: Chart on STD testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on STD testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on STD testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on STD testing - Year-over-year growth 2022-2027 (%)
    • 6.6 Cervical cancer testing - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Cervical cancer testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Cervical cancer testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Cervical cancer testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Cervical cancer testing - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by Application
      • Exhibit 54: Market opportunity by Application ($ million)
      • Exhibit 55: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 58: Chart on Comparison by End-user
      • Exhibit 59: Data Table on Comparison by End-user
    • 7.3 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 7.4 Diagnostic and imaging centers - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Diagnostic and imaging centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Diagnostic and imaging centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Diagnostic and imaging centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Diagnostic and imaging centers - Year-over-year growth 2022-2027 (%)
    • 7.5 Home care settings - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Home care settings - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Data Table on Home care settings - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Chart on Home care settings - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Home care settings - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 72: Market opportunity by End-user ($ million)
      • Exhibit 73: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 France - Market size and forecast 2022-2027
      • Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 111: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ million)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 123: Abbott Laboratories - Overview
              • Exhibit 124: Abbott Laboratories - Business segments
              • Exhibit 125: Abbott Laboratories - Key news
              • Exhibit 126: Abbott Laboratories - Key offerings
              • Exhibit 127: Abbott Laboratories - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 128: Becton Dickinson and Co. - Overview
              • Exhibit 129: Becton Dickinson and Co. - Business segments
              • Exhibit 130: Becton Dickinson and Co. - Key news
              • Exhibit 131: Becton Dickinson and Co. - Key offerings
              • Exhibit 132: Becton Dickinson and Co. - Segment focus
            • 12.5 Bio Rad Laboratories Inc.
              • Exhibit 133: Bio Rad Laboratories Inc. - Overview
              • Exhibit 134: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 135: Bio Rad Laboratories Inc. - Key news
              • Exhibit 136: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 137: Bio Rad Laboratories Inc. - Segment focus
            • 12.6 Danaher Corp.
              • Exhibit 138: Danaher Corp. - Overview
              • Exhibit 139: Danaher Corp. - Business segments
              • Exhibit 140: Danaher Corp. - Key news
              • Exhibit 141: Danaher Corp. - Key offerings
              • Exhibit 142: Danaher Corp. - Segment focus
            • 12.7 F. Hoffmann La Roche Ltd.
              • Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.8 FUJIFILM Corp.
              • Exhibit 148: FUJIFILM Corp. - Overview
              • Exhibit 149: FUJIFILM Corp. - Business segments
              • Exhibit 150: FUJIFILM Corp. - Key offerings
              • Exhibit 151: FUJIFILM Corp. - Segment focus
            • 12.9 GE Healthcare Technologies Inc.
              • Exhibit 152: GE Healthcare Technologies Inc. - Overview
              • Exhibit 153: GE Healthcare Technologies Inc. - Business segments
              • Exhibit 154: GE Healthcare Technologies Inc. - Key offerings
              • Exhibit 155: GE Healthcare Technologies Inc. - Segment focus
            • 12.10 Hologic Inc.
              • Exhibit 156: Hologic Inc. - Overview
              • Exhibit 157: Hologic Inc. - Business segments
              • Exhibit 158: Hologic Inc. - Key news
              • Exhibit 159: Hologic Inc. - Key offerings
              • Exhibit 160: Hologic Inc. - Segment focus
            • 12.11 Illumina Inc.
              • Exhibit 161: Illumina Inc. - Overview
              • Exhibit 162: Illumina Inc. - Business segments
              • Exhibit 163: Illumina Inc. - Key news
              • Exhibit 164: Illumina Inc. - Key offerings
              • Exhibit 165: Illumina Inc. - Segment focus
            • 12.12 Myriad Genetics Inc.
              • Exhibit 166: Myriad Genetics Inc. - Overview
              • Exhibit 167: Myriad Genetics Inc. - Product / Service
              • Exhibit 168: Myriad Genetics Inc. - Key offerings
            • 12.13 PerkinElmer Inc.
              • Exhibit 169: PerkinElmer Inc. - Overview
              • Exhibit 170: PerkinElmer Inc. - Business segments
              • Exhibit 171: PerkinElmer Inc. - Key news
              • Exhibit 172: PerkinElmer Inc. - Key offerings
              • Exhibit 173: PerkinElmer Inc. - Segment focus
            • 12.14 QIAGEN NV
              • Exhibit 174: QIAGEN NV - Overview
              • Exhibit 175: QIAGEN NV - Product / Service
              • Exhibit 176: QIAGEN NV - Key news
              • Exhibit 177: QIAGEN NV - Key offerings
            • 12.15 Quest Diagnostics Inc.
              • Exhibit 178: Quest Diagnostics Inc. - Overview
              • Exhibit 179: Quest Diagnostics Inc. - Business segments
              • Exhibit 180: Quest Diagnostics Inc. - Key offerings
              • Exhibit 181: Quest Diagnostics Inc. - Segment focus
            • 12.16 Siemens AG
              • Exhibit 182: Siemens AG - Overview
              • Exhibit 183: Siemens AG - Business segments
              • Exhibit 184: Siemens AG - Key news
              • Exhibit 185: Siemens AG - Key offerings
              • Exhibit 186: Siemens AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 187: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 188: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 189: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 190: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 191: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 192: Inclusions checklist
                • Exhibit 193: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 194: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 195: Research methodology
                • Exhibit 196: Validation techniques employed for market sizing
                • Exhibit 197: Information sources
              • 13.5 List of abbreviations
                • Exhibit 198: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              womens health diagnostics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis